title: Red wine and cardiovascular risks.
abstract: Numerous epidemiological studies indicate that a moderate intake of alcohol is associated with a reduced risk of morbidity and mortality secondary to cardiovascular diseases. Alcohol intake from any type of alcoholic beverage appears beneficial, but red wine seems to confer additional health benefits because of the presence of red wine polyphenolic compounds (RWPC). On the basis of clinical and experimental data, the favourable effect of moderate intake of alcohol results to its action on lipid profile, hemostatic parameters, and reduction of inflammation markers. RWPC exert numerous effects including antioxidant and free radical properties, anti-aggregatory platelet and anti-thrombotic activities. Moreover, RWPC are powerful vasodilators and contribute to the preservation of the integrity of the endothelium and inhibition of smooth muscle cell proliferation and migration. All these effects of red wine might interfere with atherosclerotic plaque development and stability, vascular thrombosis and occlusion. Although, red wine might be of therapeutic benefit in cardiovascular diseases, prospective controlled clinical studies are still lacking.
authors.affiliation: Biologie neuro-vasculaire intégrée, CNRS, UMR 6214-INSERM Faculté de médecine, Angers.
authors.forename: A H
authors.initials: AH
authors.lastname: Lagrue-Lak-Hal
authors.forename: R
authors.initials: R
authors.lastname: Andriantsitohaina
mesh_terms: D000428:Alcohol Drinking; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000502:physiology; D050197:Atherosclerosis / Q000517:prevention & control; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control*; D003116:Color; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D005419:Flavonoids / Q000302:isolation & purification / Q000627:therapeutic use; D006801:Humans; D023421:Models, Animal; D010636:Phenols / Q000302:isolation & purification / Q000627:therapeutic use; D059808:Polyphenols; D000077185:Resveratrol; D018570:Risk Assessment; D013267:Stilbenes / Q000302:isolation & purification / Q000627:therapeutic use; D013927:Thrombosis / Q000517:prevention & control; D014652:Vascular Diseases / Q000517:prevention & control; D014665:Vasodilator Agents / Q000302:isolation & purification / Q000627:therapeutic use; D014920:Wine / Q000032:analysis
chemical_list: D005419:Flavonoids; D010636:Phenols; D059808:Polyphenols; D013267:Stilbenes; D014665:Vasodilator Agents; D000077185:Resveratrol